A K Agrawal AIIMS, New Delhi India
Source of Support: None, Conflict of Interest: None
One hundred and eleven patients with, one hundred and twenty-one hydrocele were treated with tetracycline sclerotherapy. These were divided into four groups depending upon the volume of fluid aspirated. Ten ml of oxytetracycline was injected after complete aspiration. Repeat accumulations were retapped and sclerosed. These patients were followed up for six months. 98 percent of patients were cured on six months of follow up. Patients with large hydroceles tended to be erratic on follow up. The commonest side effects included pain in 39.8 percent and induration in 16.9 percent of patients. Tetracycline sclerotherapy is a safe and effective modality for the treatment of primary hydrocele.